ITGAM and melanoma: Quantitative FACS-based analysis confirmed the myeloid-cell-rich phenotype (Gr-1+/CD11b+ or CD11b+) of stably dedifferentiated syngeneic melanomas that also showed higher levels of Tnf and its downstream target Ccl2 as shown by ELISA assay of tissue lysates (Fig. 7f–h and Supplementary Fig. 9a).